[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsControl group: All the patients are required to fill the consent form to be able to enter the trial. 50 patients admitted to the COVID ward with definitive moderate COVID19 diagnosis and randomly divided into two arms( each with 50 patients). in the intervention arm, the treatment regimen will consist of interferon beta 1a and national protocol for COVID treatment. interferon beta 1a 44 micrograms will be administered subcutaneously 3-5 doses a day for 10 days and paraclinical tests and vital signs and blood O2 saturation will be assessed according to the plan by experienced health providers", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: all the patients are required to fill the consent form to be able to enter the trial. 50 patients admitted in the COVID ward with definitive moderate COVID19 diagnosis and randomly divided into two arms( each with 50 patients). in the intervention arm, the treatment regimen will consist of sofosbuvir, interferon beta 1a, and national protocol for COVID treatment. interferon beta 1a 44 micrograms will be administered subcutaneously 3-5 doses a day and sofosbuvir 400 mg orally and daily for 10 days and paraclinical tests and vital signs and blood O2 saturation will be assessed according to the plan by experienced health providers", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1219, "treatment_name": "Sofosbuvir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]